A nasal spray is extremely effective in preventing the disease caused by all known variants of the SARS-CoV-2 virus

English: A dramatic photo shot of nasal spray in action. A hand sprays a mist of nasal spray droplets on a black background. (Photo credit: Wikipedia)

English: A dramatic photo shot of nasal spray in action. A hand sprays a mist of nasal spray droplets on a black background.

(Photo credit: Wikipedia)

A nasal spray is extremely effective in preventing the disease caused by all known variants of the SARS-CoV-2 virus

Researchers have developed a molecule that is, when administered nasally, extremely effective in preventing the disease caused by all known variants of the SARS-CoV-2 virus. The molecule can be a key tool in preparing for future pandemics, as it is aimed at preventing both the transmission and spread of the virus.

In laboratory animal studies, a molecule known as TriSb92, developed by researchers at the University of Helsinki, has been confirmed as affording effective protection against coronavirus infection. The molecule identifies a region in the spike protein of the coronavirus common to all current variants of the virus and inhibits its functioning.

“When administered nasally, the TriSb92 molecule is extremely effective in preventing infection, and experiments carried out in cell cultures indicate that it also encompasses the very latest variants, including XBB, BF7 and BQ.1.1,” explains Postdoctoral Researcher Anna R. Mäkelä from Professor Kalle Saksela’s research group.

Animal models have also demonstrated that, unlike face masks, the molecule can, when sprayed into the nose, prevent infection even after a few hours of exposure.

According to the researchers, the molecule remains fully functional at room temperature for at least 18 months, making it well suited for use as a nasal spray.

The results have been published in the Nature Communications journal.

Anticipation of future viral variants

While the worst stage of the coronavirus pandemic is, at least for the time being, behind us, nasally administered protection can be a crucial help in preventing the spread of the virus in the future.

“The latest variants effectively avoid the immune protection provided by both vaccines and the COVID-19 disease, and current vaccines are not effective in preventing transmission,” Mäkelä says.

Moreover, the nasal spray can protect those people from serious disease who do not gain sufficient immunity from vaccines, such as immunocompromised individuals and elderly.

According to the researchers, the molecule could also work against future animal-borne close relatives of SARS-CoV-2, which are expected to be the cause of entirely new coronavirus pandemics.

“Since the region in the coronavirus’s spike protein affected by the TriSb92 molecule has remained almost unchanged in all viral variants so far emerged, it can be assumed to be effective also against future SARS-CoV-2 variants,” Mäkelä confirms.

“The easily and inexpensively produced TriSb92 could be a very important first line of defence in curbing such a new pandemic, pending the development, production and distribution of vaccines,” she adds.

A copyable approach

According to the researchers, the sherpabody-technology used is also applicable to the prevention of many other viral diseases, particularly influenza and other respiratory viruses.

“The whole approach stems from a technical solution based on a binder protein platform developed in Finland, which was not originally intended for the development of an antiviral drug. It provides an opportunity for many other new initiatives based on the accurate identification of diseased cells or pathogens in patients,” Mäkelä says.

See Also

In the next stage, the molecule must be tested in clinical trials, after which it could be made commercially available.

“Successful commercialisation of the nasal spray could lead to the creation of a thriving Finnish business,” Mäkelä points out.

 

Original Article: A nasal spray protects against coronavirus infection – Effective also against recent immune-evasive variants

More from: University of Helsinki 

 

 

The Latest Updates from Bing News

Go deeper with Bing News on:
TriSb92
    Feed has no items.
Go deeper with Bing News on:
Sherpabody technology
  • Technology News

    U.S. intelligence agencies are scrambling to embrace the AI revolution, convinced they’ll otherwise be smothered in data as sensor-generated surveillance tech further blankets the planet ...

  • Body Electric

    November 16, 2023 • On Body Electric, host Manoush Zomorodi investigates the relationship between our technology and our bodies... and she has a challenge for YOU. May 21, 2024 • Many of us ...

  • The Most Profound Ways Space Technology Benefits Us

    Prevailing satellite technology allows a clearer, more clarified view of Earth's climate, including — but not limited to — notable shifts in the planet's composition, metrics related to ...

  • Office of Technology & Entrepreneurial Partnerships

    The Office of Technology & Entrepreneurial Partnerships (OTEP) is responsible for all aspects of Intellectual Property management for the University. The OTEP can help external industry and ...

  • A Primer on Investing in Transformative Technology

    Her expertise is in personal finance and investing, and real estate. Learn about our editorial policies The technology sector is an inescapably huge investment opportunity for both corporate ...

What's Your Reaction?
Don't Like it!
0
I Like it!
0
Scroll To Top